Cargando…

An Efficient T (1) Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI

Noninvasive cell tracking in vivo has the potential to advance stem cell-based therapies into the clinic. Magnetic resonance imaging (MRI) provides an excellent image-guidance platform; however, existing MR cell labeling agents are fraught with limited specificity. To address this unmet need, we dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haedicke, Inga E., Loai, Sadi, Cheng, Hai-Ling Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604499/ https://www.ncbi.nlm.nih.gov/pubmed/31316306 http://dx.doi.org/10.1155/2019/3475786

Ejemplares similares

A manganese porphyrin-based T1 contrast agent for cellular MR imaging of human embryonic stem cells
por: Venter, Andrei, et al.
Publicado: (2018)

An enzyme-activatable and cell-permeable Mn(III)-porphyrin as a highly efficient T(1) MRI contrast agent for cell labeling
por: Haedicke, Inga E., et al.
Publicado: (2016)

Sonophore labeled RGD: a targeted contrast agent for optoacoustic imaging
por: Haedicke, Katja, et al.
Publicado: (2017)

Blood-pool MRI assessment of myocardial microvascular reactivity
por: Loai, Sadi, et al.
Publicado: (2023)

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
por: Li, Li, et al.
Publicado: (2013)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

A scale to measure MRI contrast agent sensitivity
por: Alvares, Rohan D. A., et al.
Publicado: (2017)

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents
por: Vollett, Kyle D. W., et al.
Publicado: (2023)

Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T(1) Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells
por: Kim, Taeho, et al.
Publicado: (2011)

Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging
por: Fox, Matthew S., et al.
Publicado: (2016)

Magnetic core–shell nanowires as MRI contrast agents for cell tracking
por: Martínez-Banderas, Aldo Isaac, et al.
Publicado: (2020)

A primer on in vivo cell tracking using MRI
por: Cheng, Hai-Ling Margaret
Publicado: (2023)

Concurrent Dual Contrast for Cellular Magnetic Resonance Imaging Using Gadolinium Oxide and Iron Oxide Nanoparticles
por: Loai, Yasir, et al.
Publicado: (2012)

Human Serum Albumin Labelled with Sterically-Hindered Nitroxides as Potential MRI Contrast Agents
por: Dobrynin, Sergey, et al.
Publicado: (2020)

Caveolae-mediated mesenchymal stem cell labelling by PSS-coated PLGA PFOB nano-contrast agent for MRI
por: Quang, Hieu Vu, et al.
Publicado: (2018)

Labeling Human Mesenchymal Stem Cells with Fluorescent Contrast Agents: the Biological Impact
por: Boddington, Sophie E., et al.
Publicado: (2010)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
por: Loai, Sadi, et al.
Publicado: (2021)

Contrast agents for photoacoustic imaging: a review of stem cell tracking
por: James, Soorya, et al.
Publicado: (2021)

The Effectiveness of Ferritin as a Contrast Agent for Cell Tracking MRI in Mouse Cancer Models
por: Lee, Chan Wha, et al.
Publicado: (2017)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Highly efficient magnetic labelling allows MRI tracking of the homing of stem cell‐derived extracellular vesicles following systemic delivery
por: Han, Zheng, et al.
Publicado: (2021)

Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking
por: Taylor, Arthur, et al.
Publicado: (2014)

Ultrashort Echo Time for Improved Positive-Contrast Manganese-Enhanced MRI of Cancer
por: Nofiele, Joris Tchouala, et al.
Publicado: (2013)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Gd/Y Hydroxide Nanosheets as Highly Efficient T(1)/T(2) MRI Contrast Agents
por: Li, Xin, et al.
Publicado: (2020)

Correction: Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking
Publicado: (2015)

Contrasting Expression of Keratins in Mouse and Human Embryonic Stem Cells
por: Maurer, Jochen, et al.
Publicado: (2008)

Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences
por: Loai, Sadi, et al.
Publicado: (2022)

In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia
por: Li, Xiang-Xiang, et al.
Publicado: (2013)

Tracking embryonic hematopoietic stem cells to the bone marrow: nanoparticle options to evaluate transplantation efficiency
por: Sweeney, Sean K., et al.
Publicado: (2018)

Bright Ferritin—a Reporter Gene Platform for On-Demand, Longitudinal Cell Tracking on MRI
por: Szulc, Daniel A., et al.
Publicado: (2020)

Tracking the mechanical dynamics of human embryonic stem cell chromatin
por: Hinde, Elizabeth, et al.
Publicado: (2012)

MRI contrast agents: from molecules to particles
por: Laurent, Sophie, et al.
Publicado: (2017)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Cyclodextrins: promising scaffolds for MRI contrast agents
por: Sembo-Backonly, Berthe Sandra, et al.
Publicado: (2021)

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

Novel MRI Contrast Agent from Magnetotactic Bacteria Enables In Vivo Tracking of iPSC-derived Cardiomyocytes
por: Mahmoudi, Morteza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pr4125dtcsti8iost5u4pn9nea